Therapeutic Focus 2013: Respiratory – Medical Marketing and Media

Therapeutic Focus 2013: Respiratory
Medical Marketing and Media
(At press time, its March ad-com vote had been postponed.) Delivered via Theravance's inhaler Ellipta, the successor promises more convenient once-a-day dosing than Advair, which is known as Seretide abroad. Whether asthma, COPD or pulmonary

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *